<DOC>
	<DOCNO>NCT02536950</DOCNO>
	<brief_summary>This open-label , non-randomized , pilot study determine safety feasibility insulin-only bionic pancreas .</brief_summary>
	<brief_title>An Outpatient Study Automated Blood Glucose Control With Insulin-Only Bionic Pancreas</brief_title>
	<detailed_description>A total 16 subject , age 18-45 , enrol crossover study . The study consist three 7-day study arm follow order , one usual care arm , one bionic pancreas insulin arm static glucose target , one bionic pancreas insulin arm dynamic glucose target .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Pancrelipase</mesh_term>
	<mesh_term>Pancreatin</mesh_term>
	<criteria>Type 1 diabetes least 1 year insulin pump ≥ 6 month Prescription medication regimen stable &gt; 1 month Subject comprehend write English Female patient sexually active must acceptable method contraception e.g . oral contraceptive pill , diaphragm , IUD ( Intrauterine Device ) Female patient must negative urine pregnancy test Informed Consent Form sign subject Lives work within 60 minute drivetime radius Stanford University Willing remain within 60 minute drivetime radius Stanford University 3 7day study arm ( 21 day ) Have someone 18 year age live , Current alcohol abuse ( intake average &gt; 3 drink daily last 30 day ) , use marijuana within 1 month enrollment , substance abuse ( use within last 6 month control substance marijuana without prescription ) Subject history diagnose medical eat disorder Subject history visual impairment would allow subject participate Subject active skin condition would affect sensor placement Subject adhesive allergy Subjects require intermediate longacting insulin ( NPH , Neutral Protamine Hagedorn , detemir glargine ) Subjects require antidiabetic medication insulin ( oral injectable ) Current use oral/inhaled glucocorticoid medication , judgment investigator would contraindication participation study Unwilling unable refrain drink 2 drink hour 4 drink day use marijuana trial Subject active Graves ' disease Subjects inadequately treat thyroid disease celiac disease History liver disease Renal failure dialysis Personal history cystic fibrosis , pancreatitis , pancreatic tumor , pancreatic disease besides type 1 diabetes Any known history coronary artery disease Abnormal EKG ( electrocardiogram ) consistent coronary artery disease increase risk malignant arrhythmia Congestive heart failure ( establish history congestive heart failure , low extremity edema , paroxysmal nocturnal dyspnea , orthopnea ) History transient ischemic attack ( TIA ) stroke Seizure disorder , history nonhypoglycemic seizure within last two year , ongoing treatment anticonvulsant History hypoglycemic seizure ( grandmal ) coma last year History pheochromocytoma : episodic treatment refractory ( require 4 medication achieve normotension ) hypertension paroxysms tachycardia , pallor , headache personal family history MEN 2A ( multiple endocrine neoplasia ) , MEN 2B , neurofibromatosis , von HippelLindau disease History adrenal disease tumor Hypertension systolic blood pressure ≥160 mm Hg diastolic blood pressure ≥100 despite treatment Untreated inadequately treat mental illness Electrically powered implant ( e.g . cochlear implant , neurostimulators ) might susceptible RF interference Unable completely avoid acetaminophen duration study Established history allergy severe reaction adhesive tape must use study History eat disorder within last 2 year , anorexia , bulimia , diabulemia omission insulin manipulate weight History intentional , inappropriate administration insulin lead severe hypoglycemia require treatment Lives frequents area poor Verizon wireless network coverage ( would prevent remote monitor ) Any factor , opinion site principal investigator overall principal investigator , would interfere safe completion study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>44 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>bionic pancreas</keyword>
	<keyword>closed-loop control</keyword>
	<keyword>artificial pancreas</keyword>
</DOC>